Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?

PURPOSE OF REVIEW: Pulmonary arterial hypertension (PAH) is a progressive disease with high mortality. A greater understanding of the physiology and function of the cardiovascular system in PAH will help improve survival. This review covers the latest advances within cardiovascular magnetic resonanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjellström, Barbro, Lindholm, Anthony, Ostenfeld, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Imaging in Heart Failure (J Schulz-Menger, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495997/
https://www.ncbi.nlm.nih.gov/pubmed/32870447
http://dx.doi.org/10.1007/s11897-020-00479-7
_version_ 1783583000158535680
author Kjellström, Barbro
Lindholm, Anthony
Ostenfeld, Ellen
author_facet Kjellström, Barbro
Lindholm, Anthony
Ostenfeld, Ellen
author_sort Kjellström, Barbro
collection PubMed
description PURPOSE OF REVIEW: Pulmonary arterial hypertension (PAH) is a progressive disease with high mortality. A greater understanding of the physiology and function of the cardiovascular system in PAH will help improve survival. This review covers the latest advances within cardiovascular magnetic resonance imaging (CMR) regarding diagnosis, evaluation of treatment, and prognostication of patients with PAH. RECENT FINDINGS: New CMR measures that have been proven relevant in PAH include measures of ventricular and atrial volumes and function, tissue characterization, pulmonary artery velocities, and arterio-ventricular coupling. SUMMARY: CMR markers carry prognostic information relevant for clinical care such as treatment response and thereby can affect survival. Future research should investigate if CMR, as a non-invasive method, can improve existing measures or even provide new and better measures in the diagnosis, evaluation of treatment, and determination of prognosis of PAH.
format Online
Article
Text
id pubmed-7495997
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-74959972020-09-29 Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines? Kjellström, Barbro Lindholm, Anthony Ostenfeld, Ellen Curr Heart Fail Rep Imaging in Heart Failure (J Schulz-Menger, Section Editor) PURPOSE OF REVIEW: Pulmonary arterial hypertension (PAH) is a progressive disease with high mortality. A greater understanding of the physiology and function of the cardiovascular system in PAH will help improve survival. This review covers the latest advances within cardiovascular magnetic resonance imaging (CMR) regarding diagnosis, evaluation of treatment, and prognostication of patients with PAH. RECENT FINDINGS: New CMR measures that have been proven relevant in PAH include measures of ventricular and atrial volumes and function, tissue characterization, pulmonary artery velocities, and arterio-ventricular coupling. SUMMARY: CMR markers carry prognostic information relevant for clinical care such as treatment response and thereby can affect survival. Future research should investigate if CMR, as a non-invasive method, can improve existing measures or even provide new and better measures in the diagnosis, evaluation of treatment, and determination of prognosis of PAH. Springer US 2020-09-01 2020 /pmc/articles/PMC7495997/ /pubmed/32870447 http://dx.doi.org/10.1007/s11897-020-00479-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Imaging in Heart Failure (J Schulz-Menger, Section Editor)
Kjellström, Barbro
Lindholm, Anthony
Ostenfeld, Ellen
Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?
title Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?
title_full Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?
title_fullStr Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?
title_full_unstemmed Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?
title_short Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?
title_sort cardiac magnetic resonance imaging in pulmonary arterial hypertension: ready for clinical practice and guidelines?
topic Imaging in Heart Failure (J Schulz-Menger, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495997/
https://www.ncbi.nlm.nih.gov/pubmed/32870447
http://dx.doi.org/10.1007/s11897-020-00479-7
work_keys_str_mv AT kjellstrombarbro cardiacmagneticresonanceimaginginpulmonaryarterialhypertensionreadyforclinicalpracticeandguidelines
AT lindholmanthony cardiacmagneticresonanceimaginginpulmonaryarterialhypertensionreadyforclinicalpracticeandguidelines
AT ostenfeldellen cardiacmagneticresonanceimaginginpulmonaryarterialhypertensionreadyforclinicalpracticeandguidelines

Ejemplares similares